Prevalence of Respiratory Syncytial Virus in Adult Patients with Respiratory Illnesses in Low to Middle-Income Countries: A Systematic Review and Meta-Analyses
Overall, there is a considerable disease burden associated with RSV among 18-59-year-old high-risk and ≥ 50-year-old adults with respiratory illnesses in low, lower-middle, and upper-middle income countries, highlighting the need for improved prevention programs for RSV in these populations.
Authors
- Yolanda Penders (ORCID: https://orcid.org/0000-0002-7606-7987)
- Adriana Guzmán-Holst (ORCID: https://orcid.org/0000-0002-6753-2541)
- Desirée Van Oorschot (ORCID: https://orcid.org/0000-0002-0382-0333)
- Digant Gupta
- Vikas Verma
- Amandeep Kaur
Institutions
- Age UK (GB)
- GlaxoSmithKline (Belgium) (BE)
- Bridge Pharma (United States) (US)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1007/s40121-025-01265-5
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00